Cholesterol inhibition, cancer, and coronary heart disease

MarkR Goldstein, StephenB Kritchevsky, Michael S Goggins

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)127-128
Number of pages2
JournalThe Lancet
Volume340
Issue number8811
DOIs
StatePublished - Jul 11 1992
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl CoA Reductases
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Coronary Disease
Cholesterol
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cholesterol inhibition, cancer, and coronary heart disease. / Goldstein, MarkR; Kritchevsky, StephenB; Goggins, Michael S.

In: The Lancet, Vol. 340, No. 8811, 11.07.1992, p. 127-128.

Research output: Contribution to journalArticle

Goldstein, MarkR ; Kritchevsky, StephenB ; Goggins, Michael S. / Cholesterol inhibition, cancer, and coronary heart disease. In: The Lancet. 1992 ; Vol. 340, No. 8811. pp. 127-128.
@article{efe4e1812dc04f1a91ba586da2650ab9,
title = "Cholesterol inhibition, cancer, and coronary heart disease",
author = "MarkR Goldstein and StephenB Kritchevsky and Goggins, {Michael S}",
year = "1992",
month = "7",
day = "11",
doi = "10.1016/0140-6736(92)90461-B",
language = "English (US)",
volume = "340",
pages = "127--128",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8811",

}

TY - JOUR

T1 - Cholesterol inhibition, cancer, and coronary heart disease

AU - Goldstein, MarkR

AU - Kritchevsky, StephenB

AU - Goggins, Michael S

PY - 1992/7/11

Y1 - 1992/7/11

UR - http://www.scopus.com/inward/record.url?scp=0026659618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026659618&partnerID=8YFLogxK

U2 - 10.1016/0140-6736(92)90461-B

DO - 10.1016/0140-6736(92)90461-B

M3 - Article

VL - 340

SP - 127

EP - 128

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8811

ER -